AXT (AXTI) shares now trade well below their recent equity offering price, presenting a compelling buying opportunity ahead of Q2 2026 earnings. The company expects accelerating revenue, margin recovery, and a backlog exceeding $100 million, with management guiding $34 million in revenue and $0.06–$0.08 non-GAAP EPS. Record Indium Phosphide revenue and improving gross margins above 30% could signal operational improvements and potential profitability. This outlook suggests a positive inflection point for AXT's financial performance in the near future.
AXT, Inc. has secured a long-term supply deal with Lumentum Holdings, reinforcing its role in providing indium phosphide wafers for advanced tech products. The company projects a nearly 90% revenue increase, fueled by strong demand from the AI sector...
Corning's shares dropped 18% following its second-quarter earnings report, marking the stock's worst day since 2002. Although the company beat earnings and revenue estimates with 78 cents per share and $4.74 billion in revenue, its forecast for the c...
